BIOPORTO A/S

No trades
See on Supercharts
Market capitalization
797.281MDKK
−0.200DKK
−75.923MDKK
28.969MDKK
310.568M
Beta
0.52

About BIOPORTO A/S

CEO
Anthony Pare
Headquarters
Hellerup
Founded
1917
ISIN
DK0011048619
Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The firm products specialize in coagulation, immunodeficiency, diabetes, peptide hormones, and kidney diseases. Its portfolio consists of NGAL Test, NGAL ELISA kits, MBL ELISA kits, and Antibody Shop. The company was founded on November 22, 1917 and is headquartered in Hellerup, Denmark.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Performance
Revenue to profit conversion
Earnings
‪0‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good

See all brokers